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The past 3 to 4 decades have seen a remarkable change in the 
incidence and type of poisoning. A number of new compounds have 
been added to the list of potentially poisonous materials. Poisoning is 
the fourth most common cause of mortality in rural India. Aluminium 
phosphide (AlP) an extremely lethal poisonous compound, is a solid 
fumigant, which has been in extensive use since the 1940 [2,3]. It has 
rapidly become one of the most commonly used grain fumigants 
because of its properties which are considered to be near ideal, it is 
toxic to all stages of insects highly potent and does not affect seed 
bioavailability as well as free from toxic residues [2-4]. Acute poisoning 
is on the rise in many countries and similar trend has been observed in 
India. AlP is now a day’s more common because of its easy availability 
and widely used as grain preservatives at homes and in ware houses. It 
becomes poisonous by liberating phosphine (PH3) gas after coming in 
contact with moisture PH3 affects all the body systems and proves 
fatal.[5] 
        The poisoning is generally suicidal rarely homicidal and 
occasionally accidental (Children) and is common in younger age group. 
Poisoning is on rise in many countries and is often a neglected health 
problem compounded with the problem of difficulty in the diagnosis. 
Poisoning is largely preventable and majority of them dies within one to 
six hour of poison exposed or 6-8 hours of ingestion.  AlP poisoning is 
the most common cause of suicidal death in India.[5] 
         Keeping in mind of increasing incidence of poisoning 
specially AlP amongst younger population the present study was 
undertaken for their clinical presentation with salient features and 
effective treatment so as to prevent the morbidity and mortality and 
evaluate Prognostic variables. 
        
2. Materials & Methods 
All cases of poisoning suspected or confirmed admitted in the 
Nehru Chikistisalya B.R.D. Medical College, Gorakhpur during the period 
of October 2012 to March 2014 constituted the clinical material   of this 
study. All of them and/or their relatives and accompanying person were 
interrogated for the detailed history regarding. Poison ingested, its 
amount, time, whether sealed or exposed and any poison material seen 
on the body. Any symptom appeared when and severity in the form of 
nausea and vomiting, pain in abdomen and diarrhoea, Efforts will be 
made to know the cause of poisoning.   
        Thorough clinical examination was performed specially for 
vital signs, level of consciousness pupils and systemic examination to 
reveal any involvement of the system. 
The gastric lavage with Potassium permanganate (KMNO4, 1: 
10000) two to three times was performed and gastric aspirate was 
preserved.  After gastric wash 100 gms of activated charcoal was 
administered along with medicated liquid paraffin just to absorb PH3 
and enhance excretion through GIT by purgation. Adequate hydration 
and renal perfusion was maintained with IV fluids and vasopressors 
(Dopamine and /or Dobatamine). Efforts were made to combat shock 
and maintain systolic BP around 90 mm Hg.  
Oxygen was given to combat hypoxia. Magnesium sulphate 1 
gm in 100 ml of 5% dextrose hourly   for 3 to 6 hours then 6 hourly for 5 
to 6 days in 62 cases and their result of efficacy was compared with 50 
cases who had not given Magnesium. 
The diagnosis was established with Silver Nitrate (AgNO3) 
test in gastric aspirate from breathing air and urine which turns the 
AgNo3 black if AlP (Celphos) is taken. 
       They were subjected to routine examination of blood for 
hemoglobin, total and differential leucocytes count, general blood 
picture. Urine examination in detail especially for the presence of RBC, 
pus cells etc. 
Screening and/or X-ray chest and 12 leads standard E.C.G. 
Serum was subjected to liver and renal function tests along with blood 




Aluminium Phosphide (AlP) poisoning is extremely lethal poisoning. Ingestion is 
usually suicidal in intention Phosphine, which is liberated when AlP comes in contact with 
moisture, is injurious and effect the cellular respiration there by it became lethal. The present 
study was under taken to study the salient features and ways to combat the deleterious effect of 
poisoning.  
One hundred and twelve cases of proved AlP poisoning by AgNO3 Test constituted 
the clinical material. Each and every patient and /or relatives, friends were interrogated 
regarding amount of exposed or unexposed poison taken, when taken and the time when 
symptoms started appearing after ingestion of poison.  
The overall  incidence  of all type of poisoning was 0.29% i.e. 200 cases of poisoning 
out of total admission  67189 in medical wards during Oct. 2012 to March 2014. Amongst these 
200 cases there was 112 cases (56%) of AlP poisoning. They were mainly from 3rd decade of life 
(mean age ± SD = 22.45 ± 5.3 years) with male to female ratio of 2.7: 1. 73.2% from rural area 
and mostly were educated from High School to Graduate level (85 cases or 75.6%) Main causes 
were set-back in life, unemployment, home conflicts etc.  
                    Good prognosis depends on the earliest the hospitalization with effective measures 
taken to combat the shock and promote the rapid excretion of poison through urine and gastro 
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3. Observations 
200 cases of poisoning out of 67189 total admissions (0.29% 
or 2/1000 admissions) in Medical Ward of Nehru Chikitsalya, B.R.D. 
Medical College, Gorakhpur during the period of October 2012 to March 
2014 were included in this study. Of these 200 cases, 112 cases (56 %) 
were of Aluminium Phosphide (AlP) poisoning whose diagnosis was 
confirmed by AgNO3 test. The incidence of AlP poisoning amongst total 
admissions was 0.16%, There was one hundred and twelve cases (56%) 
of Aluminium Phosphide poisoning  followed by 40 cases (20%) of  
organo phosphorus  poisoning  and rest of them were of different 
poisoning/over dosage of  material  etc. ( Table  1 )  
Table -1: Incidence of poisoning in hospitalized cases (n=200)  
Type of poisoning No of cases % 
Aluminium Phosphide 112 56 
Organo phosphorus 40 20 
Rodenticides 14 7 
Anti-psychotic 2 1.0 
Dhatura  2 1.0 
Naphthalene 10 5 
Diazepam 8 4 
Bhang 2 1.0 
Acid 4 2.0 
Gamaxene 2 1.04 
Unknown 4 2.0 
TOTAL 200 100% 
The  age ranged  from 12 to 35 years ( mean ± SD= 22.45 ± 
5.3 years with male to female ratio of 2.7 : 1 Out of  200 cases . 102 
cases  ( 91 %)  were of suicidal and accidental in 4 cases only. Eighty 
two of them (73.28 %) were from rural area and students (46.4 %). 
(Table-2)  
Table 2: Socio –Economic status in Aluminium Phosphide cases 
(n=112) 
Occupation No. of Cases % 
Students        52     46.4 
House wife        18     16.1 
Farmers          2       1.8 
Labourer          6       5.3 
Salesman         4       3.6 
Employed persons        14     12.5 
Unemployed persons        16     14.2 
Marital status:   
Married         44     39.3 
Unmarried         68     60.7 
Sixty eight (60.7 %) were unmarried of whom 54 were males 
(48.20 %). Many of them were educated from high school to graduate 
level. (84 cases, 75 %) and some of them had family conflict (33.9 %), 
failure in examination and unemployment, (26.88 %) (Table 3 and 4).  
Table 3: Educational Status  
Education No. of cases Percentage 
Uneducated 10 8.9 
Class VIII or less 14 12.5 
High School 22 19.5 
Inter mediate 26 23.2 
Graduate 36 32.1 
Post graduate 4 3.6 
Total 112 100 
        Table 4: Profile of various precipitating Factor 
Precipitating Factors No. of cases % 
Family conflicts 38 33.9 
Failure in love 30 26.8 
Financial crisis 20 17.8 
Failure in examination 16 14.3 
Accidental  4 3.6 
Unknown 4 3.6 
TOTAL 112 100 
As depicted   in Table 5 all of them had nausea and vomiting 
with increased thirst (71.4 %) and pain in abdomen (42.8 %) more over 
epigastrium and adjacent  area with epigastric tenderness Respiratory 
system revealed  increased respiratory rate, creptiations and  rhonchi 
mainly at bases. This was progressing to adult respiratory distress 
syndromes (23.2%) Twenty cases (21.4%) were drowsy and 18 of them 
(16.9%) were unconscious. Eighty four cases (75%) were in shock with 
systolic BP< 90 mm Hg and pulse was not recordable in 20 cases 
(17.8%).  
Table 5: Clinical Manifestation  











1. Shock ( Systolic BP) 
< 90 mm hg 
> 90 mm hg 
2. Pulse 
    Normal Pulse 
    Tachycardia  
    Bradycardia  
    Not recordable  
3. Level of Conciousness 
    Delirium 
    Stupor  




   S1`. Muffled 
   S3     Present 
7. B/L Basal crepts 
8. Epigastric tenderness 





























































Laboratory evaluation (Table 6) was mainly to assess the 
general condition and prognosis. Anemia was mild (10- 12 gm%, 12 
cases) to moderate (8 to 10 gm %, 8 cases) degree. Leucopenia 
indicating towards the severity of toxicity was noted in 5 cases (TLC= 
3100 ± 280.5/c mm). Altered renal function in the form  of raised blood 
urea ( > 40 mg % , 92 . 6 ± 20.7 mg %) and serum creatinine (> 1.5 mg%, 
2.8±1.6 mg%) was observed in 36 (32.1% ) and 35 cases (32.1%)  
respectively. 





Hemoglobin – 8 to 10  gm. %  
10 to 12 gm % 






8.4-12 gm, 10.2 ±4.6 gm. % 
Leucopenia TLC < 5000/ cm. 




3100- 4500/cmm   
3102. 5 ± 2805/cmm 
Blood Urea> 40mg %  
Range , mean ± SD  
36 32.1%  
45.6- 108.6 mg % 
92.8 ± 12.92 mg % 
S-creatinine  > 1.5 mg % 




1.6-4.6 mg % , 3.2 ± 1.92mg %  
SGOT  ( AST)  > 40  w 
Range, mean  ± SD 
10 8.8 % 
45- 92 IU ,, 68.9 ± 10.6 IU 
SGPT  (ALT) > 40 w  
Range, mean ± SD  
25 22.3  %  
56- 172 IU, 126.8 ± 30.9 IU 
S.bilirubin  > 1.5 mg %  
Range, means ± SD  
6 5.3  % 
1.5-5.2 mg % , 3.8 ± 2.4 mg %  
S. magnesium < 1.5 mg %  
Range, means ± SD 
18 16.1 % 
0.98-1.5 mg%, 1.24±0.36 mg%  
S. Magnesium > 2.5 mg 
Range, means ±  SD 
6 5.3 % 
2.8-4.2 mg % , 3.2 ±  0.96 mg 
% 
Serum potassium > 5 meq/l 
Range, means ±  SD 
10 8.8 % 
5.2-7.8 meq/l, 6.26± 1.8 meq/l 
Similarly raised level of transiminases i.e. SGOT > 40 IU (68.9 
± 10.6 I.U.) and SGPT > 40 IU (112.6 ± 30.81 IU), was present in 10 (8.5 
%) and 25 (22.3 %) cases with hyper bilirubinamia (S. bilirubin > 1.5 
mg %, 3.6 ± in 6 cases 5.3 %. Serum Magnesium was above 2.5 mg% in 6 
cases (5.3%, 3.2±0.98 mg%) and less than 1.5 mg % off in 18 cases (16.1 
%, 0.98±1.5 mg%) Sodium and Potassium levels were within normal 
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range except in 10 cases (8.8%) in whom serum potassium was raised 
above 5 meq/l (6.26±1.8 meq/l) X-ray chest revealed hilar congestion 
in 26 cases (23.2%) who later on developed respiratory distress. 
Electrocardiogarms (Table 7) revealed various changes 
indicating towards the cardiac injury as evidenced by sinus /ventricular 
tachycardia (60 cases, 53.5%)  ST-T changes in the form of ST elevation 
with concavity upwards, or depression (28.8%) while 2 of them had 
.wide QRS and bundle branch block (L.B.B.B – 3.5% R.B.B.B 1.7 %) and 
ventricular eptopics observed in 6 and 4 cases respectively.  
Table 7: Electro Cardiogram Findings 
E.C.G. Changes No. of cases % 
Sinus Tachycardia  60 53.5 
Sinus  Bradycardia 4 3.5 
ST-T Changes 30 26.8 
ST-T Changes with wide QRS 2 1.7 
Ventricular ectopics  4 3.5 
Atrial Fibrillation  2 1.7 
R.B.B.B. 2 1.7 
L.B.B.B. 4 3.5 
All patient were managed by gastric levage with Potassium 
Permanganate (1: 10,000) two to three times depending on amount 
consumed then placed activated charcoal 100 gm and liquid paraffin in 
stomach just to absorb the toxin and to accelerate excretion by diarrhea, 
Acceleration of excretion through urine (renal route) achieved by 
maintaining the adequate hydration and renal perfusion with IV fluids. 
The systolic BP was maintained around 90mm Hg by Dopamine and 
Dobutamine which will combat the shock. Dialysis was done in 6 cases 
and 4 of them expired due to acute renal failure Oxygen was 
administered through polymask or by endotracheal intubation (18 
cases)  
          Magnesium sulphate therapy was given in 62 cases that is 
immediately   1 g, in 100 ml of  5% dextrose within 15 to 20 minutes 
and later on hourly for 3 hours , later on 6 hourly  for 5-6 days. It was 
observed that there was no significant .effect on reducing the mortality 
i.e. 28 death out of 62 cases  (45.1%) as compared to 20 deaths in 50 
patient who have not received Mg SO 4 (P> 0.05) 
Fourty eight (42.8 %) deaths were seen in the present series 
of cases (Table -8). Mortality was not related to amount (tablet) taken 
even though 16 deaths (50%) were seen in person who had taken to 2 
tablets. Maximum deaths occurred   within 6 hours (33 deaths out of 90 
cases or 35 %) of ingestion of poison. Similarly the unexposed (sealed) 
tablet resulted in more deaths (39.2 %). Persons having abnormal ECG 
findings and in shock had also high mortality (39.2 %). There were 
more deaths in persons having  low magnesium level (10 death out of 
18 cases or 8.4 %, Table -8 ) as compared to patient with normal 
magnesium level( 38 deaths out of 88 cases or 33.9 %).Deaths were 
mostly seems to be due to multi organ failure.   




% Deaths % 
1- Tablets (ALP) - 1 tab. 
     consumed           2 tab 
                                    3 tab 
                                    4 tab 
                                   Not known 
Duration of Ingestion < 6 Hours 
                 >6 Hours up to 24 Hours 
- Exposed tablets 
-Unexposed tablets 
2- Abnormal ECG. 
3- No. shock ( normal vitals) 
- In shock (syst. BP < 90mm Hg) 
            -Deaths within 24 hours 
           - Deaths after 24 hours 
4- Altered Renal function 
5- Altered Liver Function 
6-Magnesium -<1.5 mg(1.34±0,7) 
   (meq /l – 1.5 -2.5 (1.92±0.15) 
                    - >2.5 (3.2±0,2) 


















































































4. Discussion   
                   Aluminum phosphide (AlP), commonly marketed as Celphos. 
Quickphos sunfume and Phosphene is easily available and a deadly 
poison due to Phosphine gas which is liberated when it comes in contact 
with water and / or hydrochloric acid of stomach. It is rapidly becoming 
a very commonly used agent for self poisoning in many countries [1,2, 9, 
10] and now termed as Delebrate Self Poisoning (DSP) [11]. 
                In the present study the incidence of poisoning was 0.29 % 
i.e. 200 cases of poisoning out of total admissions of 67189 in medical 
ward during the period of October 2012 to March 2014. Amongst these 
200 cases of different poisoning there were 112 cases of AlP poisoning 
giving the incidence of 56%. Amongst total admissions the incidence of 
(AlP) poisoning   came to 0.16%. This study confirms the finding of the 
literature [1,2,9,10] and agreed with the term DSP[11]. Kapoor et al[12] 
in their study at Allahabad reported 2.3 % in total admissions and 11.7 
% of AlP poisoning amongst the all poisoning cases. They reported the 
sex ratio of male to female 2:1 as we reported 2.7: 1 and main age group 
involved was 16 to 25 years (73.2 %). 
        As described in literature [1,2,6,10-12] the present cases too 
manifested with nausea, vomiting, abdominal pain, loose motion and 
restlessness. Cardiovascular manifestation was in the form of 
tachycardia, thready pulse, hypotension, palpitation and breathlessness. 
ECG changes were observed in 26.8 % of cases ranging from ST-T 
elevation to prolonged PR and QRS with various blocks. These ECG 
changes and cardiac manifestations were due to toxic injury to 
myocardium and presented as focal myocadardial necrosis [3]. The 
changes in action membrane potential due to alteration in permeability 
of Na+, Mg++ and Ca++ ions [14] Both hypo and hypermegnesemia were 
also results in ECG abnormalities [14,15] and seen in present series 
(16.1 % of cases) which  might be due to an oxidative stress which 
buffer the Mg++ leading to increased susceptibility  to oxygen , free 
radical , injury and accelerated liquid peroxidation [16].  
           It is the Phosphine (PH3). Gas which is released in the 
stomach gets absorbed and circulates which manifest as various early 
signs and symptoms. The delayed onset to toxicity is because of some 
AlP is absorbed and metabolaise in liver will result in slow release of 
PH3 gas thus causing the delayed onset of toxicity signs and symptoms 
[8-13]. The ingested AlP leads to high superoxide dismulase activity and 
low catalyses levels that result in increased formation of free radicals 
and accelerated lipid peroxidation [13,15,17]. This in turn will result in 
cellular membrane damage with disruption of ionic barrier, nucleic acid 
damage and cell death. This will give rise to various ECG changes and 
cardiac arrhythmias. Phosphine is excreted through breath and urine 
Cellular hypoxia as a consequence of non competitive inhibition of 
cytochrome oxidase enzyme of mitochondria will lead to wide spread 
damage to other organs.  
         Laboratory investigations revealed leucopenia (TLC< 
5000/cmm) in 4.4% cases, raised serum creatinine (>1.5 mg %) in 
32.1% cases, 2-3 fold increase in serum transaminases in 22. 3% of 
cases and altered serum electrolytes with hypomagnesimea (< 1.5 
mg%) in 16.1 % of cases.  All these findings indicate towards the 
severity of toxicity , metabolic  acidosis  and poor prognosis ,which  
emphasized that laboratory evaluation was mainly to assess the 
severity of the disease and prognosis[1,2,15,17].  The altered level of 
Magnesium, Sodium and Potassium will lead to various ECG changes in 
the  form of ST-T changes to various blocks even ventricular tachycardia 
and ventricular  fibrillation. We too observed various types of ECG 
changes as depicted in Table 6 and 7. Which on echo cardiography 
reveal a generalized left ventricular hypokinesea, decreased ejection 
fraction etc. [17-20]. Chug et al[18] stressed that serum cortisol level 
was usually decreased in severe AlP poisoning cases which often proved 
fatal and indicate the severity of toxicity to myocardium . The fatal dose 
usually varied from 015 to 0.5 gm. However most of the patient has 
ingested [2-3] or more tablets which invariable results fatal as we 
observed too [1,2,4].  
      All patients were managed conservatively as no specific 
antidote to the poison is known. All the steps in management as 
described by Bajpai [21].  Were taken to provide symptomatic and 
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supportive aid to the patients till, Phosphine is excreted through GIT, 
Lungs and Kidneys. Magnesium Sulphate was given to 62 cases and 
revealed no significant effect on reducing morbidity and mortality on 
comparing with controls. But anyhow as described in literature 
[1,2,21,22], the MgSO4  was proved useful in reducing the various 
cardiac conduction defects and  ventricular rate. MgSO4 stabilizes the 
cardiac cell membrane and thereby act as a weak anti arrhythmic agent 
and control the supra ventricular arrhythmias [1,2,21,22]. Similarly 
Siwacha et al[23] also observed no significant effect of MgSO4 in 
reducing the mortality. 
      The stress has been laid in the quick and efficient 
management to prevent toxicity effect and to reduce mortality and 
morbidity. Measures will be taken to prevent absorption of AlP from GI 
tract and promote Phosphine excretion from Lung and Kidney by means 
of maintaining the renal perfusion with intravenous fluids with low 
dosage (4-6 mg / kg /min.) Dopamine, Dobutamine to maintain the BP 
around 90 mm Hg [1,2,21,23] Diuretics can be given when systolic BP 
was above 90mm. Hg. to enhance the excretion of PH3 through urine  
Acidosis will be managed with Sodium  Bicarbonate  50-100 meq/l  
intravenously till carbonate level raised  to 18-20 meq/l². The role of 
cortisone is controversial even some clinicians recommend to give 
hydrocortisone in the dosage of 200 - 400 mg 4-6 hourly intravenously. 
This is to combat shock and to reduce the dosage of dopamine [17,18] .  
            The fatal dosage of AlP is 0.15 – 0.5 gm.4 however most of the 
person taken 2-3 tablets or even more (38 cases) which invariably 
results to death (20 deaths 52.6%)  The average time interval between 
the ingestion of AlP and death varies from 3- 48 hours and 95% of death 
usually occurs within 24 hours [10].  In the present series of cases the 
mortality was 42.8% and 33 deaths ( 68.7% ) occurred  within 6 hours 
and these persons consumed unexposed AlP which is more injurious 
and fatal[1,2].  Mortality depends on dosage and time of ingestion of 
poison and when symptoms start appearing. The shorter the time of 
appearing clinical manifestation the fatality will be more.  It is the 
severity of poisoning,  duration of shock ,  failure to revert,  shock  to 
normal life,  resuscitative  measures and severity of electrolyte  
imbalance  and acidosis will affect the prognosis . Deaths after 24 hours 
(10 deaths or 8.9 %) was usually due to shock acidosis ARDS, cardiac 
dysarrtythmia [10]. Non survivors have more severe hypotension, 
metabolic acidosis etc. as compared to survivors.  
        The mortality is highly variable ranging from 37-100% most 
commonly reach up to 60% even in the experience hands and well 
equipped hospital 4.11.  In the present series of 112 cases of AlP poisoning 
there were 48 deaths giving the incidence of 42.8%. 
 
5. Conclusion 
          Deaths by the AlP and Organophosphorus poisoning are the 
commonest form of poisoning in India and in this part of U.P. (East U.P.) 
It produces phosphine gas which result in mitochondrial poisoning 
leading to organ damage.  There is no known antidote for AlP poisoning 
which liberate toxic Phosphine when it comes in contact with water and 
hydrochloric acid of stomach, It cannot be detoxified  but with all 
suitable supportive measures its  absoption can be prevented  and 
promate the  excretion through kidney, Lung and GIT. It can be 
managed conservatively to provide symptomatic relief and supportive 
aid to help to promote excretion of Phosphine through Lungs, Kidney 
and GIT.  With the steps for management described by Bajpai [20] can 
reduce the mortality and morbidity. 
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